Bridge to Life Receives FDA 510(k) Clearance for Multi-Sourced Belzer UW® and MPS® Solutions with Expanded Labeling for MPS® Across All Abdominal Organs

DULUTH, Ga., Oct. 7, 2025 /PRNewswire/ — Bridge to Life, Ltd. (BTL), a global leader in organ preservation and perfusion, today announced it has received FDA 510(k) clearance for its multi-sourced Belzer UW® and MPS® organ preservation solutions. Notably, this clearance includes expanded…